Pharmacokinetic study of netilmicin

Area of Science:

• Pharmacology
• Clinical Pharmacy
• Drug Metabolism

Background:

• Netilmicin is an aminoglycoside antibiotic used for serious infections.
• Understanding its pharmacokinetic profile is crucial for optimizing therapeutic efficacy and minimizing toxicity.

Purpose of the Study:

• To determine the pharmacokinetic parameters of netilmicin following intravenous infusion in healthy human subjects.
• To characterize the absorption, distribution, metabolism, and excretion (ADME) of netilmicin.

Main Methods:

• Intravenous infusion of netilmicin (2 mg/kg) into 10 healthy volunteers.
• Serum concentration monitoring at the end of infusion.
• Urine collection for 8 hours post-infusion to assess drug excretion.
• Pharmacokinetic analysis using a two-compartment model.

Main Results:

• Peak serum netilmicin concentration reached 16.56 mug/ml at the end of infusion.
• Urinary excretion accounted for 39% of the infused dose within the first 8 hours.
• Elimination data were successfully modeled using a two-compartment pharmacokinetic model.

Conclusions:

• Netilmicin exhibits predictable pharmacokinetic behavior in healthy individuals.
• The observed elimination and excretion patterns provide valuable data for dosing recommendations.
• Further studies may explore netilmicin pharmacokinetics in patient populations with varying physiological conditions.